Venus Remedies Limited (VENUSREM.NS) NSE
Currency In INR
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In INR
| Market Cap | 10.96B |
| Enterprise Value | 10.78B |
| P/E Ratio | 22 |
| PEG Ratio | 0.17 |
| Price/Sales Ratio | 2.96 |
| Price/Book Ratio | 3.41 |
| Enterprise/Revenue | 2.94 |
| Enterprise/EBITDA | 14.48 |
| Fiscal Year | March 31, 2026 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | 0.13 |
| Operating Margin | 0.15 |
| Return On Assets | 0.12 |
| Return On Equity | 0.17 |
| Revenue | 7.7B |
| Revenue/Share | 571.83 |
| Gross Profit | 2.68B |
| EBITDA | 1.47B |
| Net Income | 1.03B |
| Diluted EPS | 76.89 |
| Total Cash | 1.04B |
| Total Cash/Share | 78.12 |
| Total Debt | 124.1M |
| Total Debt/Equity | 0.02 |
| Current Ratio | 2.44 |
| Book Value Per Share | 496.59 |
| 52-Week Change | 293.56 |
| 52-Week High | 1,943.8 |
| 52-Week Low | 416 |
| Moving Average 50 Days | 1,211.03 |
| Moving Average 200 Days | 805.55 |
| Average Volume | 90,667 |
| Shares Outstanding | 13.37M |
| % Held by Institutions | N/A |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |